Skip to content
JNJ Johnson & Johnson NYSE
161.84 USD 0.87% +1.39
OPEN 160.88
DAY RANGE 162.25 - 160.16
52 WEEK RANGE 175.97 - 144.95
Interactive Brokers Logotype

Buy JNJ stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 389.8B
Enterprise value 397.3B
Trailing pe 31.123077
Forward pe 14.65942
Peg ratio 14.65942
Price to sales ttm 4.577735
Price to book mrq 5.6642866
Enterprise to revenue 4.666
Enterprise to ebitda 12.914


Fiscal year ends 2023-12-31
Most recent quarter 2023-12-31
Profit margin 0.41279
Operating margin 0.22108
Return on assets ttm 0.08334
Return on equity ttm 0.18308
Income statement
Revenue ttm 85.2B
Revenue per share ttm 33.613
Quarterly revenue growth 0.073
Gross profit ttm 58.6B
Ebitda 33.9B
Net income to common ttm 13.3B
Diluted eps ttm 5.2
Quarterly earnings growth yoy 0.15
Balance sheet
Total cash mrq 22.9B
Total cash per share mrq 9.518
Total debt mrq 30.4B
Total debt to equity mrq 44.249
Current ratio mrq 1.156
Book value per share mrq 28.572
Cash flow
Operating cash flow ttm 22.8B
Levered free cash flow ttm 19.8B

Stock statistics

Shares outstanding 2.4B
Float shares 2.4B
Avg 10 volume 7.9M
Avg 90 volume 7.4M
Shares short 12.3M
Short ratio 1.87
Short percent of shares outstanding 0.0050999997
Percent held by insiders 0.00093000004
Percent held by institutions 0.7132

Stock price summary

Fifty two week low 144.95
Fifty two week high 175.97
Fifty two week change 3.837
Beta 0.535
Day 50 ma 158.3988
Day 200 ma 159.3771

Dividends and splits

Forward annual dividend rate 4.76
Forward annual dividend yield 0.029417217724492
Trailing annual dividend rate 4.76
Trailing annual dividend yield 0.029417217724492
5 year average dividend yield 2.66
Payout ratio 0.90379995
Dividend date 2024-03-05
Ex dividend date 2024-02-16
Last split factor 2-for-1 split
Last split date 2001-06-13

Johnson & Johnson (JNJ) company profile

Johnson & Johnson (NYSE: JNJ) is a medical company that engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the segments of Consumer, Pharmaceutical, and Medical Devices. The company’s main focus is on products related to human health and well-being.